December 18, 2017 3:00 AM ET


Company Overview of Dimension Therapeutics, Inc.

Key Executives for Dimension Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Annalisa Mary Jenkins MBBS, FRCP95 RelationshipsChief Executive Officer52
Thomas R. Kassberg No RelationshipsPresident57
Mary T. Thistle 7 RelationshipsPrincipal Financial & Accounting Officer and COO57
Khandan Baradaran Ph.D.No RelationshipsHead of Quality--
K. Reed Clark Ph.D.10 RelationshipsSenior VP & Head of Pharmaceutical Development 55
View More Key Executives

Dimension Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Karah Herdman Parschauer 7 RelationshipsUltragenyx Pharmaceutical Inc.39
James M. Wilson M.D., Ph.D. 93 RelationshipsRegenxbio Inc.62
Emil D. Kakkis M.D., Ph.D. 14 RelationshipsUltragenyx Pharmaceutical Inc.57
Terence R. Flotte M.D. 69 RelationshipsApplied Genetic Technologies Corporation--
Ian Alexander BMedSci, MBBS (Hons), Ph.D., FRACP (Paeds), HGSACG 7 RelationshipsDimension Therapeutics, Inc.--
View All Board Members

Dimension Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$500.0K
Total Value of Options
Compensation as of Fiscal Year
Dimension Therapeutics, Inc. CEO Compensation
Industry Average


Sunesis Pharmaceuticals, Inc. Announces Management Changes
December 15, 2017 10:09 PM ET
ContraFect Corporation Announces Executive Changes
December 15, 2017 9:52 PM ET
Biotoscana Investments S.A. Hires Ivan French as Executive Vice President of Research and Development
December 15, 2017 9:36 PM ET
Minerva Neurosciences, Inc. Announces Management Changes
December 15, 2017 9:31 PM ET
Applied Genetic Technologies Corporation Announces Resignation of R. Guyer from the Board
December 15, 2017 9:16 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Dimension Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at